Clinical efficacy of immune checkpoint inhibitors for cancer of unknown primary: a multi-center retrospective study

Clinical efficacy of immune checkpoint inhibitors for cancer of unknown primary: a multi-center retrospective study

Abstract Background Patients diagnosed with cancer of unknown primary (CUP) have limited treatment options, resulting in a dismal prognosis. The efficacy of immune checkpoint inhibitors (ICIs) in these patients is still unclear. Methods We collected the clinical data of these patients retrospectivel...

Full description

Saved in:
Bibliographic Details
Main Authors: Haowen Wang, Siqi Song, Yuzhou Nie, Jinting Wu, Linyue Pan, Qizhen Zou, Gaizhen Kuang, Chen Chen, Xiaochen Zhang, Wenfeng Li, Shirong Zhang
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Cancer
Subjects:
CUP
ICIs
Unfavorable subgroup
Immunotherapy
Survival.
Online Access:https://doi.org/10.1186/s12885-025-14778-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14778-6

Similar Items